Advertisement
Full Length Article| Volume 164, P90-95, April 2018

Download started.

Ok

Incidence, clinical characteristics, and associated diseases in patients with immune thrombocytopenia: A nationwide population-based study in Taiwan

  • Author Footnotes
    1 These authors contributed equally to this work.
    Shu-Ruei Wu
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC
    Search for articles by this author
  • Hsiao-Ching Kuo
    Affiliations
    Research Center of Medical Informatics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC
    Search for articles by this author
  • Wei-Chun Huang
    Affiliations
    Critical Care Center and Cardiovascular Medical Center, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC

    School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
    Search for articles by this author
  • Yung-Feng Huang
    Affiliations
    Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC

    Department of Pediatrics, National Defense Medical Center, Taipei, Taiwan, ROC
    Search for articles by this author
  • Yee-Hsuan Chiou
    Affiliations
    Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
    Yu-Hsiang Chang
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC

    Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
    Bao-Ren Nong
    Correspondence
    Corresponding author at: Department of Pediatrics, Kaohsiung Veterans General Hospital, No. 386, Dazhong 1st Rd., Zuoying Dist., Kaohsiung City 81362, Taiwan, ROC.
    Footnotes
    1 These authors contributed equally to this work.
    Affiliations
    Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC

    Department of Pediatrics, National Defense Medical Center, Taipei, Taiwan, ROC
    Search for articles by this author
  • Author Footnotes
    1 These authors contributed equally to this work.
Published:February 27, 2018DOI:https://doi.org/10.1016/j.thromres.2018.02.146

      Highlights

      • The overall incidence of immune thrombocytopenia was 2.59/100,000 person-years.
      • Hepatitis B and C only in immune thrombocytopenia patients were higher in Taiwan.
      • Hyperthyroidism and hypothyroidism increased risks of immune thrombocytopenia.
      • Serious bleeding among immune thrombocytopenia patients was low.

      Abstract

      Introduction

      Immune thrombocytopenia (ITP) is an immune-mediated disease; it has been reported to be associated with several diseases. The data on ITP in patients with hepatitis B, tuberculosis, or thyroid diseases are relatively scarce. In addition, these diseases are not rare in Taiwan, together with hepatitis C and Helicobacter pylori which are also related to ITP.

      Methods and materials

      We identified 1223 ITP patients and characterized these patients between 2000 and 2013 from the National Health Insurance Research Database. The adult ITP patients were matched with non-ITP patients.

      Results

      The overall incidence of ITP was 2.59/100,000 person-years. The frequencies of hepatitis B and C in adult ITP patients were much higher than those indicated in previous studies. The frequencies of non-traumatic intracerebral hemorrhage and gastrointestinal bleeding during hospitalization among ITP patients were low. The diseases associated with increased risks of ITP included hepatitis B (OR = 18.70, 95% CI = 9.71–36.03), hepatitis C (OR = 54.43, 95% CI = 15.94–185.88), hepatitis B and hepatitis C (OR = 7.02, 95% CI = 1.47–33.56), tuberculosis (OR = 5.37, 95% CI = 2.72–10.61), Helicobacter pylori infection (OR = 5.93, 95% CI = 3.16–11.10), hyperthyroidism (OR = 3.43, 95% CI = 2.09–5.64), hypothyroidism (OR = 6.70, 95% CI = 2.35–19.13), and simple and unspecified goiter (OR = 2.68, 95% CI = 1.43–5.03).

      Conclusions

      Surveying for the diseases which are frequent and related to increased risks of ITP among patients with newly diagnosed ITP should be considered.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cooper N.
        • Bussel J.
        The pathogenesis of immune thrombocytopaenic purpura.
        Br. J. Haematol. 2006; 133: 364-374https://doi.org/10.1111/j.1365-2141.2006.06024.x
        • Rodeghiero F.
        • Stasi R.
        • Gernsheimer T.
        • Michel M.
        • Provan D.
        • Arnold D.M.
        • et al.
        Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
        Blood. 2009; 113: 2386-2393https://doi.org/10.1182/blood-2008-07-162503
        • Neunert C.
        • Lim W.
        • Crowther M.
        • Cohen A.
        • Solberg L.
        • Crowther M.A.
        • et al.
        The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood.
        American Society of Hematology. 2011; : 4190-4207https://doi.org/10.1182/blood-2010-08-302984
      1. Wu C-Y, Kuo KN, Wu M-S, Chen Y-J, Wang C-B, Lin J-T. Early helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009;137: 1641–8.e1–2. doi:10.1053/j.gastro.2009.07.060.

        • Marieke Schoonen W.
        • Kucera G.
        • Coalson J.
        • Li L.
        • Rutstein M.
        • Mowat F.
        • et al.
        Epidemiology of Immune Thrombocytopenic Purpura in the General Practice Research Database.
        in: Br J Haematol. Vol. 145. Blackwell Publishing Ltd, 2009: 235-244https://doi.org/10.1111/j.1365-2141.2009.07615.x
        • Moulis G.
        • Palmaro A.
        • Montastruc J.-L.
        • Godeau B.
        • Lapeyre-Mestre M.
        • Sailler L.
        Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
        Blood. 2014; 124: 3308-3315https://doi.org/10.1182/blood-2014-05-578336
        • Moulis G.
        • Germain J.
        • Comont T.
        • Brun N.
        • Dingremont C.
        • Castel B.
        • et al.
        Newly diagnosed immune thrombocytopenia adults: clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
        Am. J. Hematol. 2017; 92: 493-500https://doi.org/10.1002/ajh.24702
        • Lee J.Y.
        • Lee J.-H.
        • Lee H.
        • Kang B.
        • Kim J.-W.
        • Kim S.H.
        • et al.
        Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea.
        Thromb. Res. 2017; 155: 86-91https://doi.org/10.1016/j.thromres.2017.05.010
        • Kurata Y.
        • Fujimura K.
        • Kuwana M.
        • Tomiyama Y.
        • Murata M.
        Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review.
        Int. J. Hematol. 2011; 93: 329-335https://doi.org/10.1007/s12185-011-0791-1
        • Behnava B.
        • Alavian S.M.
        • Asl M.A.
        The prevalence of thrombocytopenia in patients with chronic hepatitis B and C.
        Hepat Mon. Kowsar. 2006; 6
        • Chiao E.Y.
        • Engels E.A.
        • Kramer J.R.
        • Pietz K.
        • Henderson L.
        • Giordano T.P.
        • et al.
        Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.
        Arch. Intern. Med. 2009; 169: 357-363https://doi.org/10.1001/archinternmed.2008.576
        • Pockros P.J.
        • Duchini A.
        • McMillan R.
        • Nyberg L.M.
        • McHutchison J.
        • Viernes E.
        Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.
        Am. J. Gastroenterol. 2002; 97: 2040-2045https://doi.org/10.1111/j.1572-0241.2002.05845.x
        • Wu S.-R.
        • Kuo H.-C.
        Awareness of tuberculosis among patients with newly diagnosed immune thrombocytopenia in the endemic area.
        Ann Hematol. Annals of Hematology. 2017; 11: 1-2https://doi.org/10.1007/s00277-017-3081-z
        • al-Majed S.A.
        • al-Momen A.K.
        • al-Kassimi F.A.
        • al-Zeer A.
        • Kambal A.M.
        • Baaqil H.
        Tuberculosis presenting as immune thrombocytopenic purpura.
        Acta Haematol. 1995; 94: 135-138
        • Weber S.F.
        • Belard S.
        • Rai S.
        • Reddy R.
        • Belurkar S.
        • Saravu K.
        Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
        Int J Tuberc Lung Dis. 2017; 21: 466-470https://doi.org/10.5588/ijtld.16.0515
        • Lefrancais E.
        • Ortiz-Munoz G.
        • Caudrillier A.
        • Mallavia B.
        • Liu F.
        • Sayah D.M.
        • et al.
        The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors.
        Nature. 2017; 544: 105-109https://doi.org/10.1038/nature21706
        • Taiwan Tuberculosis Control Report
        Centers for Disease Control, Ministry of Health and Welfare, R.O.C. (Taiwan).
        (Available)
        • Kuwana M.
        Helicobacter pylori-Associated Immune Thrombocytopenia: Clinical Features and Pathogenic Mechanisms.
        Vol. 20. 2014: 714-723https://doi.org/10.3748/wjg.v20.i3.714
        • Jaing T.H.
        • Yang C.P.
        • Hung I.J.
        • Chiu C.H.
        • Chang K.W.
        Efficacy of helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura.
        Acta Paediatr. 2003; 92: 1153-1157
        • Cheung E.
        • Liebman H.A.
        Thyroid Disease in Patients with Immune Thrombocytopenia.
        in: Hematology/Oncology Clinics of NA. vol. 23. Elsevier Ltd, 2009: 1251-1260https://doi.org/10.1016/j.hoc.2009.08.003
        • Ioachimescu A.G.
        • Makdissi A.
        • Lichtin A.
        • Zimmerman R.S.
        Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study.
        Thyroid. 2007; 17: 1137-1142https://doi.org/10.1089/thy.2007.0066